Characteristics and quality of randomized controlled trials in the treatment of hepatocellular carcinoma (Q36753380)

From Wikidata

Jump to navigation Jump to search

scientific article published on 7 March 2007

edit

Language	Label	Description	Also known as
English	Characteristics and quality of randomized controlled trials in the treatment of hepatocellular carcinoma	scientific article published on 7 March 2007

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17342387

retrieved

16 August 2017

review article

1 reference

stated in

Europe PubMed Central

title

Characteristics and quality of randomized controlled trials in the treatment of hepatocellular carcinoma (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17342387

retrieved

16 August 2017

author name string

Toshimi Kaido

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17342387

retrieved

16 August 2017

publication date

7 March 2007

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17342387

retrieved

16 August 2017

published in

Digestive Diseases and Sciences

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17342387

retrieved

16 August 2017

volume

52

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17342387

retrieved

16 August 2017

issue

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17342387

retrieved

16 August 2017

page(s)

1108-1113

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17342387

retrieved

16 August 2017

cites work

Treatment of hepatocellular carcinoma with tamoxifen: A double-blind placebo-controlled trial in 120 patients

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17342387

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or =4 cm.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17342387

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prospective controlled trial with antiestrogen drug tamoxifen in patients with unresectable hepatocellular carcinoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17342387

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized controlled trial of tamoxifen versus placebo in inoperable hepatocellular carcinoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17342387

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17342387

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17342387

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evidence-based medicine. A new approach to teaching the practice of medicine

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17342387

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Controlled trial of tamoxifen in patients with advanced hepatocellular carcinoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17342387

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17342387

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose tamoxifen in the treatment of inoperable hepatocellular carcinoma: A multicenter randomized controlled trial

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17342387

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tamoxifen in treatment of hepatocellular carcinoma: a randomised controlled trial. CLIP Group (Cancer of the Liver Italian Programme)

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17342387

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of advanced hepatocellular carcinoma with tamoxifen and the correlation with expression of hormone receptors: a prospective randomized study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17342387

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized trial of leuprorelin and flutamide in male patients with hepatocellular carcinoma treated with tamoxifen

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17342387

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized phase III study of doxorubicin versus cisplatin/interferon alpha-2b/doxorubicin/fluorouracil (PIAF) combination chemotherapy for unresectable hepatocellular carcinoma.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17342387

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

BASL guidelines for the surveillance, diagnosis and treatment of hepatocellular carcinoma.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17342387

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized controlled trial of tamoxifen in advanced hepatocellular carcinoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17342387

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Management of hepatocellular carcinoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/17342387

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/S10620-006-9618-Y

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17342387

retrieved

16 August 2017

PubMed publication ID

17342387

1 reference

stated in

Europe PubMed Central

PubMed publication ID

17342387

retrieved

16 August 2017

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36753380&oldid=2199282634"